12 drug(s) with this reaction
31,363 total reports
Abdominal Pain Upper has been reported as an adverse reaction across 12 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 31,363 adverse event reports mention abdominal pain upper in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with abdominal pain upper, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have abdominal pain upper listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal pain upper, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
12 drug(s) manufactured by Abbvie Inc have abdominal pain upper listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, PANCRELIPASE, FENOFIBRATE, and others.
There are a combined 31,363 reports of abdominal pain upper across 12 Abbvie Inc drug(s) in the FDA adverse event database.